Thursday, 25 February 2021

Nova IVF partners with Southend Fertility to expand network in NCR

27 January 2021 | News

The combined entity will have a significant presence in Delhi NCR with a network of four comprehensive IVF centres

Source credit: Shutterstock

Source credit: Shutterstock

Asia Healthcare Holdings owned Nova IVF Fertility, which is India’s leading fertility chain has announced the expansion of its network in the National Capital Region (NCR) through a strategic partnership with Southend Fertility & IVF, a leading IVF player in Delhi NCR. Through this investment, Nova IVF Fertility will have a majority stake in Southend Fertility & IVF.

The combined entity will have a significant presence in Delhi NCR with a network of four comprehensive IVF centres including embryology labs, a network of spoke centres, a team of senior IVF clinicians and a capacity to perform more than 3500 IVF cycles annually in that region. 

On the announcement of this strategic partnership, Shobhit Agarwal, CEO, Nova IVF Fertility, said, “We welcome Southend Fertility & IVF to the Nova family and together this partnership will further strengthen the quality of IVF treatment available to patients in Delhi NCR.”

Commenting on the partnership, Dr Sonia Malik, Founder & Lead IVF Specialist & Sameer Malik, CEO, Southend Fertility & IVF said “Our partnership with Nova IVF is a merger of common ethos and respect for the science of IVF.”

According to Vishal Bali, Executive Chairman, AHH, said “Nova’s legacy as a frontrunner in the IVF sector in India and its clinical differentiation is creating new opportunities of consolidation and partnerships with leading clinicians and enterprises in different regions of the country.  Nova IVF and Southend Fertility coming together is a step in that direction which will deliver tremendous value to patients seeking IVF treatment in Delhi NCR. There are more such partnership’s under progress in the company.”

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account






Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls